{"id":"NCT00141219","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","briefTitle":"Pregabalin Peripheral Neuropathic Pain Study","officialTitle":"A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Pregabalin (150 mg - 600 mg/Day) Using a Flexible, Optimized Dose Schedule in Subjects With Peripheral Neuropathic Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-12","primaryCompletion":"2007-12","completion":"2007-12","firstPosted":"2005-09-01","resultsPosted":"2009-03-13","lastUpdate":"2021-02-09"},"enrollment":241,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetic Neuropathies","Neuralgia"],"interventions":[{"type":"DRUG","name":"pregabalin","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"To evaluate the efficacy of pregabalin, using a flexible, optimized dose schedule with dose adjustment based on Daily Pain Rating Scale (DPRS), compared to placebo in subjects with peripheral neuropathic pain.","primaryOutcome":{"measure":"Daily Pain Rating Scale (DPRS)- Mean Pain Score (ITT Population)","timeFrame":"Endpoint- Week 8 or Early Discontinuation","effectByArm":[{"arm":"Pregabalin","deltaMin":4.63,"sd":0.15},{"arm":"Placebo","deltaMin":5.13,"sd":0.21}],"pValues":[{"comp":"OG000 vs OG001","p":"0.049"},{"comp":"OG000 vs OG001","p":"0.729"},{"comp":"OG000 vs OG001","p":"0.979"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":10,"countries":["South Korea"]},"refs":{"pmids":[],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A0081037&StudyName=Pregabalin%20Peripheral%20Neuropathic%20Pain%20Study"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":162},"commonTop":["Dizziness","Somnolence","Face oedema","Oedema peripheral","Weight increased"]}}